Agency for Toxic Substances and Disease Registry. 2000a. Toxicological profile for arsenic. Atlanta: U.S. Department of Health and Human Services.
Agency for Toxic Substances and Disease Registry. 2000b. Medical management guidelines for acute chemical exposures. Vol. III. Atlanta: US Department of Health and Human Services.
Al-Mahasneh QM, Rodgers GC. 1990. An in vitro study of efficacy of activated charcoal as an adsorbent for arsenical salts [Abstract]. Presented at: International Congress on Clinical Toxicology, Poison Control and Analytical Toxicology, LUXTOX 90; 1990 May 2-5, Luxembourg.
American Medical Association. 1986. Drugs used in the treatment of poisoning. In: AMA Drug Evaluations, 6th ed. Chicago: American Medical Association. p. 1641-3.
Anonymous. 1987. Reduction of children's arsenic exposure following relocation-Mill Creek, Montana. MMWR 36:505-7.
Anonymous. 1991. Product information: succimer (Chemet). Fort Washington (PA): McNeil Consumer Products.
Anonymous. 1999a. Arsenic: medical management. TOMES CPS (Toxicology, Occupational Medicine and Environmental Series Information Services/Consolidated Point Solution), MEDITEXT [CD-ROM Version]. Englewood (CO): Micromedex, Inc.
Anonymous. 1999b. Arsenic: hazard management. TOMES CPS (Toxicology, Occupational Medicine and Environmental Series Information Services/Consolidated Point Solution), HAZARDTEXT [CD-ROM Version]. Englewood (CO): Micromedex, Inc.
Cullen NM, Wolf LR, St. Clair D. 1995. Pediatric arsenic ingestion. Am J Emerg Med 1995;13:432-5.
Daya MR, Irwin R, Parshley MC, Harding J, Burton BT. 1989. Arsenic ingestion in pregnancy [Abstract]. Vet Hum Toxicol 31:347.
Fournier L, Thomas G, Garnier R, Buisine A, Houze P, Pradier F, et al. 1988. 2,3-Dimercaptosuccinic acid treatment of heavy metal poisoning in humans. Med Toxicol 3:499-504.
Goldfrank LR, Howland MA, Kirstein RH. 1986. Heavy metals. In: Goldfrank LR, Flomenbaum NE, Lewin NA, et al., editors. Goldfrank's toxicologic emergencies, 3rd ed. Norwalk (CT): Appleton-Century-Crofts. p. 609-18.
Graziano JH, Cuccia D, Friedheim E. 1978. The pharmacology of 2,3-dimercaptosuccinic acid and its potential use in arsenic poisoning. J Pharmacol Exp Ther 207:1051-5.
Inns RH, Rice P. 1993. Efficacy of dimercapto chelating agents for the treatment of poisoning by percutaneously applied dichloro(2-chlorovinyl)arsine in rabbits. Hum Exp Toxicol 12:241-6.
Kersjes MP, Maurer JR, Trestrail JH. 1987. An analysis of arsenic exposures referred to the Blodgett Regional Poison Center. Vet Hum Toxicol 29:75-78.
Kosnett MJ, Becker CE. 1987. Dimercaptosuccinic acid as a treatment for arsenic poisoning [Abstract]. Vet Hum Toxicol 29:462.
Kreppel H, Reichl FX, Forth W, Fichtl B. 1989. Lack of effectiveness of D-penicillamine in experimental arsenic poisoning. Vet Hum Toxicol 31:1-5.
Kuruvilla A, Bergeson PS, Done AK. 1975. Arsenic poisoning in childhood. An unusual case report with special notes on therapy with penicillamine. Clin Toxicol 8:535-40.
Lee DC, Roberts JR, Kelly JJ, Fishman SM. 1995. Whole-bowel irrigation as an adjunct in the treatment of radiopaque arsenic [Letter]. Am J Emerg Med 13:244-5.
Lenz K, Hruby K, Druml W, Eder A, Gaszner A, Kleinberger G, et al. 1981. 2,3-Dimercaptosuccinic acid in human arsenic poisoning. Arch Toxicol 47:241-3.
Mitchell RD, Walberg CB, Gupta RC. 1989. In vitro adsorption properties of activated charcoal with selected inorganic compounds [Abstract]. Ann Emerg Med 18:444-5.
Roses OE, Garcia Fernandez JC, Villaamil EC, Camussa N, Minetti SA, Martinez de Marco M, et al. 1991. Mass poisoning by sodium arsenite. J Toxicol Clin Toxicol 29:209-13.
Snider TH, Wientjes MG, Joiner RL, Fisher GL. 1990. Arsenic distribution in rabbits after Lewisite administration and treatment with British anti-Lewisite (BAL). Fundam Appl Toxicol 14:262-72.
Watson WA, Veltri JC, Metcalf TJ. 1981. Acute arsenic exposure treated with oral D-penicillamine. Vet Hum Toxicol 23:164-6.
Woody NC, Kometani JT. 1948. BAL in the treatment of arsenic ingestion of children. Pediatrics 1948;1:372-8.
American Medical Association. 1985. Effects of toxic chemicals on the reproductive system: arsenic. Chicago: American Medical Association. D24:AS(1-3).
Armstrong CW, Stroube RB, Rubio T, Siudyla EA, Miller GB Jr. 1984. Outbreak of fatal arsenic poisoning caused by contaminated drinking water. Arch Environ Health 39:276-9.
Borum DR, Abernathy CO. 1995. Human oral exposure to inorganic arsenic. In: Chappell WR, Abernathy CO, Cothern CR, editors. Arsenic exposure and health. International Conference on Arsenic Exposure and Health Effects. Chicago: Science Reviews, Inc.
Chen CJ, Chuang YC, You SL, Lin TM, Wu HY. 1986. A retrospective study on malignant neoplasms of bladder, lung, and liver in blackfoot disease-endemic area in Taiwan. Br J Cancer 53:399-405.
Datta DV. 1976. Arsenic and non-cirrhotic portal hypertension. Lancet 1:433.
Enterline PE, Henderson VL, Marsh GM. 1987. Exposure to arsenic and respiratory cancer: a reanalysis. Am J Epidemiol 125:929-38.
Falk H, Caldwell GG, Ishak KG, Thomas LB, Popper H. 1981. Arsenic-related hepatic angiosarcoma. Am J Ind Med 2:43-50.
Franklin M, Bean W, Harden RC. 1950. Fowler's solution as an etiologic agent in cirrhosis. Am J Med Sci 219:589-96.
Hindmarsh JT, McCurdy RF. 1986. Clinical and environmental aspects of arsenic toxicity. CRC Crit Rev Clin Lab Sci 23:315-47.
Ishinishi N, Tsuchiya K, Vahter M, Fowler BA. 1986. Arsenic. In: Handbook on the toxicology of metals. 2nd ed. Amsterdam: Elsevier. p. 43-83.
Kyle RA, Pease GL. 1965. Hematologic aspects of arsenic intoxication. N Engl J Med 273:18-23.
LaDou J. 1997. Occupational and environmental medicine. 2nd ed. Stamford, CT: Appleton & Lange.
Lagerkvist BJ, Zetterlund B. 1994. Assessment of exposure to arsenic among smelter workers: a five-year follow-up. Am J Ind Med 25:377-88.
Le Quesne PM, McLeod JG. 1977. Peripheral neuropathy following a single exposure to arsenic. J Neurol Sci 32:437-51.
Murphy MJ, Lyon LW, Taylor JW. 1981. Subacute arsenic neuropathy: clinical and electrophysiological observations. J Neurol Neurosurg Psychiatry 44:896-900.
Pershagan G. 1986. Sources of exposure and biological effects of arsenic. In: IARC Scientific Publication No. 71. Lyon, France: International Agency for Research on Cancer. p. 45-61.
Schoolmeester WL, White DR. 1980. Arsenic poisoning. S Med J 2:198-208.
Selzer PM, Ancel MA. 1983. Chronic arsenic poisoning masquerading as pernicious anemia. West J Med 139:219-20.
Shalat SL, Walker DB, Finnell RH. 1996. Role of arsenic as a reproductive toxin with particular attention to neural tube defects. J Toxicol Environ Health 48(3):253-72.
US Environmental Protection Agency. 1984. Health assessment document for inorganic arsenic. Research Triangle Park, NC: US Environmental Protection Agency, Environmental Criteria and Assessment Office. Report No. EPA/600/8-83/021F.
US Environmental Protection Agency. 1988. Special report on ingested inorganic arsenic: skin cancer; nutritional essentiality. Washington: US Environmental Protection Agency, Risk Assessment Forum. Report No. EPA/625/3-87/013.
Valentine JL, Kang HK, Spivey G. 1979. Arsenic levels in human blood, urine, and hair in response to exposure via drinking water. Environ Res 20:24-32.
Yeh S. 1973. Skin cancer in chronic arsenicism. Hum Pathol 4(4):469-85.
Yeh S, How SW, Lin CS. 1968. Arsenical cancer of skin-histologic study with special reference to Bowen's disease. Cancer 21(2):312-39.